🔎 Trials Near Me

Home › High Blood Pressure › New York

High Blood Pressure clinical trials in New York

14 studies for High Blood Pressure are looking for participants at sites in New York.

Cities in New York

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, The Bronx
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07142356

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Icahn School of Medicine at Mount Sinai, New York
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06059638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Rochester Clinical Research - Buffalo, Buffalo
  • CHEAR Center LLC, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Albany Med Health System - Washington Avenue Extension, Albany
  • Velocity Clinical Research - Binghamton, Binghamton
  • RCR - Buffalo, Buffalo
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Drug Trials America, Hartsdale
  • NYC Research INC, Long Island City
  • Rochester Clinical Research, LLC, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Albany
  • Research Site, Buffalo
  • Research Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • St. Joseph, Liverpool
  • Nyph/Cumc, New York
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, New Windsor
  • Clinical Trial Site, North Massapequa
  • Clinical Trial Site, Poughkeepsie
  • and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

Global Paradise System US Post Approval Study

  • Albany Medical Center, Albany
  • NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn
  • University at Buffalo, Buffalo
  • and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • Albany Medical Center, Albany
  • Icahn School of Medicine at Mount Sinai, New York
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Aug 7, 2026 · NCT06402968

Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations

  • Icahn School of Medicine at Mount Sinai, New York
Recruiting
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT07539597

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Mount Kisco
  • Vanda Investigative Site, Rochester
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161

Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients

  • NYU Langone Health, New York
Recruiting
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06730230

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.